Ann Surg Oncol (2018) 25:2083–2090 https://doi.org/10.1245/s10434-018-6480-z O R I G IN AL ARTI CL E – TRAN SLATIO NA L R ESEA RCH AN D B IOM A RK ERS Troponin I2 as a Speciﬁc Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer Koichi Sawaki, MD, Mitsuro Kanda, MD, PhD, FACS, Takashi Miwa, MD, Shinichi Umeda, MD, Haruyoshi Tanaka, MD, Chie Tanaka, MD, PhD, Daisuke Kobayashi, MD, PhD, Masaya Suenaga, MD, PhD, Norifumi Hattori, MD, PhD, Masamichi Hayashi, MD, PhD, Suguru Yamada, MD, PhD, FACS, Goro Nakayama, MD, PhD, Michitaka Fujiwara, MD, PhD, and Yasuhiro Kodera, MD, PhD, FACS Department of Gastroenterological Surgery (Surgery II), Nagoya University Graduate School of Medicine, Nagoya, Japan ABSTRACT correlation coefﬁcient[ 0.7. The optimal cutoff of TNNI2 Background. Although peritoneal metastasis is a serious expression was determined as 0.00017. High TNNI2 concern in patients with gastric cancer, no acceptable and expression was signiﬁcantly and speciﬁcally associated speciﬁc biomarker is available. We aimed to identify a with peritoneal metastasis and served as an independent candidate biomarker to predict peritoneal metastasis of risk marker for peritoneal recurrence after curative gas- gastric cancer. trectomy. Prevalence of peritoneal recurrence increased in Methods. Metastatic pathway-speciﬁc transcriptome parallel with
Annals of Surgical Oncology – Springer Journals
Published: Apr 16, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
All the latest content is available, no embargo periods.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud